There were several dividend aristocrats that recently announced no increase in their payments to shareholders.
Pfizer (PFE), which is one of the leading pharmaceutical companies in the world, announced no increase in its annual dividends for the first time in 41 years. In the past decade, the company was used to increasing its dividend payments to shareholders every December. It comes as no surprise to me that PFE is not raising its dividends. The company needs to increase its drug pipeline either through research or acquisitions as most of its drugs will be facing serious generic competition after they go off patent in 2011. Furthermore, the rising payout and stagnating earnings show danger to the dividend growth investor. In order to maintain its dividend aristocrat status, Pfizer has to increase its dividends by November 2009.
Another stock that announced no increase in its dividends was State Street (STT), which received 5 billion from the Treasury several months ago. The company broke a 27 year streak of two dividend increases per year. In order to maintain its dividend aristocrat status, State Street has to increase its dividends by the end of 2010. As a holder of STT, I am planning to be a seller at $51, which is my breakeven price as I fear that TARP might limit dividend payments for financial companies which received funds from the Treasury.
Progressive (PGR), which is a dividend aristocrat as well, announced that it won’t be paying a dividend in 2008, which terminates its status of a consistent dividend performer.
As a dividend growth investor an unchanged dividend is not necessarily bearish news. Most companies don’t raise their dividends every year, but still could achieve a decent dividend growth rate. If I could exit the position at least at breakeven however, I would most probably invest in companies which could support an increasing dividend payments even during cyclical downturns.
Relevant Articles:
- Why do I like Dividend Aristocrats?
- State Street Corporation (STT) Dividend Stock Analysis.
Popular Posts
-
I review the list of dividend increases weekly, in an effort to monitor the existing dividend growth investing universe from a different ang...
-
Welcome to my latest weekly review of dividend increases. As part of my monitoring process, I review dividend increases that occured over ...
-
I review the list of dividend increases every single week, as part of my monitoring process. It's a boring activity, which teaches me le...
-
The US Stock Market has delivered great returns for patient long-term investors. You just need to have a 20 - 30 year timeframe, and avoid p...
-
Note: Article was originally posted in August 2020 The Dow Jones Industrials average is the oldest continuously updated stock index in the U...
-
One of the best reads is " Agony & Ecstasy " by JP Morgan from 2014. It found that 40% of all stocks experienced catastrophic...
-
As part of my review process, I evaluate dividend increases every week. This process helps me to see how my portfolio holdings are doing. It...
-
The S&P Dividend Aristocrats index tracks companies in the S&P 500 that have increased dividends every year for at least 25 years ...
-
My favorite perplexities of investing: I would only buy a security that fits my entry criteria, but then I would hold onto to it until it hi...
-
Dividend investing is as sexy as watching paint dry on the wall. Defining an entry criteria that selects quality dividend stocks with risi...
